Subscribe

Hamid Khoja, PhD

Articles by Hamid Khoja, PhD

Hamid Khoja, PhD

Assessing Efficacy of Fibroblast Cell Therapy in MS: Hamid Khoja, PhD

ByHamid Khoja, PhD

March 2nd 2022

The chief scientific officer of FibroBiologics discussed efficacy findings from a phase 1/2 trial.

Hamid Khoja, PhD

Assessing Safety of Fibroblast Cell Therapy in Multiple Sclerosis: Hamid Khoja, PhD

ByHamid Khoja, PhD

February 21st 2022

The chief scientific officer of FibroBiologics discussed the benefits of fibroblast cell technology in MS.

Hamid Khoja, PhD

Fibroblast Cell Therapy or Stem Cell Therapy for MS: Hamid Khoja, PhD

ByHamid Khoja, PhD

February 11th 2022

The chief scientific officer of FibroBiologics discussed the advantages of fibroblast cell therapy over stem cell therapy.

Latest Updated Articles

Trending on CGTlive®

PreBLA Meeting With FDA Sinks uniQure’s Hopes for Approval of Huntington Disease Gene Therapy AMT-130 Based Primarily on Phase 1/2 Data

Data Roundup: October 2025 Features Updates from ESMO, ESGCT, and More

Quarter Century Update: The Impact of Artificial Intelligence

© 2025 MJH Life Sciences^®

All rights reserved.